Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...

Australia’s regulatory agency rejected Biogen and Eisai’s Alzheimer’s drug Leqembi, noting that the drug's efficacy doesn't ...

BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that the Therapeutic Goods Administration (TGA) of Australia issued a public statement about the initial decision not to ...

In another positive development for the lung cancer community, NICE has also given its blessing to NHS use of MSD's $25 ...

Lilly believes Kisunla can generate blockbuster sales. Kisunla is only the second drug on the market to treat Alzheimer's ...

Chengdu Baiyu Pharmaceutical yesterday announced that it has entered into an exclusive license agreement with Swiss pharma ...

Eisai will request a reconsideration of this decision under Section 60* of the Therapeutic Goods Act within 90 days to make lecanemab available for eligible people living with early AD in Australia.

The new law was pushed by the party of Giorgia Meloni, Italy’s conservative prime minister. By Emma Bubola The stiff penalty was the potentially final step in the stunning downfall of the ...

It's the latest defeat for allies of Donald Trump seeking to change how the battleground state's votes are counted in the Nov. 5 presidential election.

In the 1990s, China began sending pandas to foreign zoos to be bred, in the hope that future generations could be released into the wild. It hasn’t gone as planned. By Mara Hvistendahl and Joy ...

Two giant pandas from China have landed in Washington, marking the first time the US capital has welcomed a new set of furry diplomats from Beijing in 24 years. Man shot, seriously injured walking ...